ManagedCareCGM

This site is intended for managed care professionals in the U.S.

This site is intended for managed care professionals in the U.S.

Professionals in Canada should visit CanadaCGM.com

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience

Source: Diabetes Care

Key Takeaway: Pilot study found rtCGM is feasible in non-ICU adult COVID-19–positive patients receiving subcutaneous insulin injections. CGM and point-of-care (POC) values correlated well with a MARD of 9.77%, and 84.8% of the sensor values in Clarke zone A and 100% in zone A or B.

Figure 1: Clarke Error grid demonstrating the relationship between sensor and POC glucose values.